about
Long-term follow-up of laparoscopic splenectomy in patients with immune thrombocytopenic purpuraTrough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia.Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia.The modified Glasgow Prognostic Scores as a predictor in diffuse large B cell lymphoma treated with R-CHOP regimen.Primary renal aspergillosis and renal stones in both kidneys associated with hematopoietic stem cell transplant.Serum microRNA-21 as a potential biomarker for response to hypomethylating agents in myelodysplastic syndromesLymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapyPrognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic SyndromeEnhanced autophagy in cytarabine arabinoside-resistant U937 leukemia cells and its potential as a target for overcoming resistance.Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based RegimensThe prognostic significance of monoclonal immunoglobulin gene rearrangement in conjunction with histologic B-cell aggregates in the bone marrow of patients with diffuse large B-cell lymphoma.Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma.Paracentric inversion-associated t(8;21) variant in de novo acute myelogenous leukemia: characteristic patterns of conventional cytogenetics, FISH, and multicolor banding analysis.Cytomegalovirus retinitis after hematopoietic stem cell transplantation with alemtuzumab.Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.Clinical outcomes and prognostic factors of empirical antifungal therapy with itraconazole in the patients with hematological malignancies: a prospective multicenter observational study in Korea.Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia.Success rate and risk factors for failure of empirical antifungal therapy with itraconazole in patients with hematological malignancies: a multicenter, prospective, open-label, observational study in KoreaSalvage therapy for acute chemorefractory leukemia by allogeneic stem cell transplantation: the Korean experience.Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome.Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients.Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes.Therapeutic use of granulocyte-colony stimulating factor could conceal residual malignant cells in patients with AML1/ETO+ acute myelogenous leukemia.The prognostic role of CD68 and FoxP3 expression in patients with primary central nervous system lymphoma.Clinical significance of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells.The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase.Aurora-A kinase inhibition enhances the cytosine arabinoside-induced cell death in leukemia cells through apoptosis and mitotic catastrophe.Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia.High-dose etoposide plus granulocyte colony-stimulating factor as an effective chemomobilization regimen for autologous stem cell transplantation in patients with non-Hodgkin Lymphoma previously treated with CHOP-based chemotherapy: a study from theIdarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome.Tear Cytokines as Biomarkers for Chronic Graft-versus-Host Disease.Induction of cytosine arabinoside-resistant human myeloid leukemia cell death through autophagy regulation by hydroxychloroquine.The role of upfront autologous stem cell transplantation in high-risk younger patients with primary central nervous system lymphoma.A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma.The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications.Lenalidomide induces apoptosis and alters gene expression in non-small cell lung cancer cells.Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia.Incidence and risk factors for carbapenem- and multidrug-resistant Acinetobacter baumannii bacteremia in hematopoietic stem cell transplantation recipients.Clinical characteristics and treatment outcomes of isolated myeloid sarcoma without bone marrow involvement: a single-institution experience.
P50
Q33375708-6BA64198-AEA8-4733-85C9-8FF32C424961Q33394772-B6476FC9-9BD6-425C-8B29-B44DAC66F4CFQ33411923-15DD6A35-5F43-4196-90C0-AEBB4F806838Q34384335-76E6F9A7-980D-48EB-B3AC-36520B6C2C50Q34501108-B36C6A40-AD84-4ECA-BD54-1B02C9EB2F70Q35087659-D4171EE4-E4BE-4520-8DE0-C32D71DFE69EQ35207251-91EF12A2-F741-496E-AC5F-9C6D16C768E5Q36185741-8BD81A9B-B604-4A03-8D9B-21C0E8860041Q36722227-F9B4E602-7997-4E18-A6E3-61AFC37C6417Q36735810-C556E828-7272-43CE-9DBF-07C2FEB8F5DDQ37045526-818AB7A1-4123-4128-8736-C028C9909731Q37065113-EEAB3C7F-356E-47D5-8183-80D8DC6E1F9DQ37161671-DB798C44-085F-4779-84D8-F1038744B69DQ37194060-63ED94E4-E97A-4612-9AB2-BF03CC8E4EC6Q37332634-54BC04BB-3D0A-4BE0-89CF-9CDB19C1C4AAQ37418841-4C9D7DC1-12DD-4BB9-B053-88CC3FA2C874Q37438385-E1BAB3F3-693F-42C4-BD7C-04A9C846F6CCQ37473671-EA427012-16DA-474D-9476-2AB97C47E620Q38406744-E31FDC19-074D-466C-9FF0-3FEB64676094Q38425292-C47306D1-4752-4E65-AD2D-DA317465B634Q38436591-5880C884-C595-4D41-92AA-F4CF53824F7EQ38455680-E6D5B809-3F11-4588-B296-8EE42A533909Q38509808-D2DC5B40-0F5B-4FDF-9ABE-CB8354AF4448Q38784265-51E1DBB6-EA14-4959-BC44-69ACA5A625C6Q38941414-44190687-B835-465A-85DC-8E6583537501Q39668893-D50F786F-5329-4337-BF65-7BA813361D35Q39669214-A47EA425-58AB-4817-A662-9D5DC311CA52Q39693181-96D3FFFF-89B1-4C36-90EC-B9698FEC3BC1Q40172956-53FC304F-E449-43E8-9D8A-B66AD8392168Q40230959-822E58A6-07BE-49E8-957D-A46C605D32FCQ40591654-B1917BC2-5DFC-4AB1-B02C-D5DEFBEDC371Q40612184-0FAE709B-70EB-4166-BEB6-C06BE3605D07Q40695745-EFAEC951-0DC0-4574-A2E9-2B73220511E1Q40831533-77A52019-34C7-46ED-9C01-82778C54B567Q40885663-B570F84C-C027-47D4-A6C5-E21EF283D459Q41017260-8B90B470-3BBF-474C-BF33-72055435B95FQ42114228-7CA41AE1-E53C-4565-9E4A-DB8909E0BD80Q42199245-38D2D124-A8C6-4E14-B8AA-68D77FDE1C6DQ42237413-8C8CCA24-B189-4915-ACBF-9A8F8755763BQ42377776-2A66201C-8B4B-4790-B1CC-4A9B0645D7D2
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Yoo Hong Min
@ast
Yoo Hong Min
@en
Yoo Hong Min
@es
Yoo Hong Min
@nl
type
label
Yoo Hong Min
@ast
Yoo Hong Min
@en
Yoo Hong Min
@es
Yoo Hong Min
@nl
prefLabel
Yoo Hong Min
@ast
Yoo Hong Min
@en
Yoo Hong Min
@es
Yoo Hong Min
@nl
P106
P31
P496
0000-0001-8542-9583